PTCH1 and amyotrophic lateral sclerosis: There is no difference in CSF Shh levels; however, the biological activity of Shh in the ALS CSF samples is compromised and shows evidence of an inhibitor to Shh signaling that acts below the Shh receptor Ptch and below the downstream Smo, but does not correlate with any measured analyte, or with markers of disease severity.